Navigation Links
Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2009
Date:3/3/2010

173,019 195,477 Deferred financing costs 11,409 11,363 Other assets 3,754 7,855 ------------------------------------------------------------------------- Total assets $ 370,059 $ 385,197 ------------------------------------------------------------------------- ------------------------------------------------------------------------- LIABILITIES AND SHAREHOLDERS' DEFICIT Current liabilities Accounts payable and accrued liabilities $ 46,324 $ 46,620 Income taxes payable 10,858 8,071 Interest payable on long-term debt 6,004 6,514 ------------------------------------------------------------------------- Total current liabilities 63,186 61,205 ------------------------------------------------------------------------- Deferred leasehold inducement 2,888 2,780 Deferred income taxes 36,778 40,577 Other tax liabilities 3,898 3,145 Long-term debt 575,000 575,000 Other liabilities 1,596 2,363 ------------------------------------------------------------------------- Total non-current liabilities 620,160 623,865 ------------------------------------------------------------------------- Shareholders' deficit Share capital Authorized: 200,000,000 Common shares, without par value 50,000,000 Class I Preference shares, without par value Common shares issued and outstanding: December 31, 2009 - 85,138,081 December 31, 2008 - 85,121,983 472,742 472,739 Additional p
'/>"/>
SOURCE Angiotech Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

Related biology technology :

1. Angiotech Pharmaceuticals Announces Conference Call and Webcast
2. Angiotech Pharmaceuticals, Inc. Announces Conference Call and Webcast
3. Angiotech Pharmaceuticals announces the commercial launch of the Option(TM) Inferior Vena Cava Filter in the United States
4. Angiotech receives approval for Quill(TM) SRS PDO, MONODERM(TM), Polypropylene and Nylon product lines for sale in Brazil
5. Angiotechs Licensee, Cook Medical, Announces CE Mark Approval and European Launch of the Zilver(R) PTX(R) Stent
6. Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2009
7. Angiotech Pharmaceuticals announces launch of Quill SRS product codes for laparoscopic gynecology procedures
8. Angiotech Pharmaceuticals, Inc. announces filing of shelf-registration statement
9. Angiotech Pharmaceuticals announces FDA approval of TAXUS(R) Liberte(R) Long Stent
10. Angiotech Pharmaceuticals, Inc. announces conference call and webcast
11. Angiotech Pharmaceuticals announces FDA 510(k) clearance of the Option(TM) Inferior Vena Cava Filter
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... MONTREAL , July 29, 2015 /PRNewswire/ - BioAmber Inc. ... Laurin , the Company,s Chief Financial Officer has resigned.  ... former Chief Financial Officer who retired in December 2014, ... search for a permanent successor.     Andy ... Mr. Laurin and ensure a smooth transition.  Andy was ...
(Date:7/29/2015)... , July 29, 2015 ... has announced the addition of the "Global ... their offering. The Global Biosimilars Market, ... of the rapidly growing biosimilars market. With the ... striving to minimize costs, biosimilars are being viewed ...
(Date:7/29/2015)...  Pfenex Inc. (NYSE MKT: PFNX) announced today that ... on Thursday, August 13, 2015, before the open of ... host a conference call to discuss the financial results ... the financial results and business update will be publicly ... 1-866-376-8058 (US) or 1-412-542-4131 (international) and reference Pfenex to ...
(Date:7/29/2015)... CITY , July 29, 2015 /PRNewswire/ - Aeterna ... today announced it has selected an optimized Erk ... milestone in the development of a new class ... MAPK pathway represents a prime target for therapeutic ... antitumor activities and survival benefits for B-Raf and ...
Breaking Biology Technology:BioAmber Announces Change in Chief Financial Officer 2BioAmber Announces Change in Chief Financial Officer 3Global Biosimilars Market to 2025: Monoclonal Antibodies (mAbs), Insulin, Interferons, G-CSF/ GM-CSF, Erythropoietins and Others 2Global Biosimilars Market to 2025: Monoclonal Antibodies (mAbs), Insulin, Interferons, G-CSF/ GM-CSF, Erythropoietins and Others 3Pfenex To Report Second Quarter 2015 Results and Provide Business Update on Thursday, August 13, 2015 2Aeterna Zentaris Announces Optimized Erk Inhibitor Compounds For Further Development 2Aeterna Zentaris Announces Optimized Erk Inhibitor Compounds For Further Development 3
... ST. LOUIS, Oct. 8 Mass casualty incidents ... natural calamities,like earthquakes or hurricanes -- raise the ... to provide treatment for all who,need it. One ... of ventilators for,people requiring respiratory support., Disaster ...
... Millstone Medical Outsourcing,announced today that the company acquired ... growing business with new and existing customers and ... facility, located at,580 Commerce Drive, includes 27,000 square ... inspection services, ultrasonic cleaning,and sterile and non-sterile packaging. ...
... that included numerous medications, trips to the emergency room and surgery to ... Unit at an Ohio hospital. Both sides of his heart were dying ... ... TUCSON, Ariz. (Business Wire EON) October 8, 2008 -- "I swelled ...
Cached Biology Technology:Allied Healthcare Launches First of Line of Ventilators Designed to Meet Demands of Mass Casualty Incidents 2Allied Healthcare Launches First of Line of Ventilators Designed to Meet Demands of Mass Casualty Incidents 3Millstone Medical Outsourcing Acquires New Facility to Accommodate Growing Business, Provide Additional Clean Room Capacity 2 "Put Down the BBQ Ribs, We've Found You a Donor Heart," Nurse Tells Patient : Ohio Father near Death Gets Second Chance at Life with CardioWest™ temporary Total Artificial Heart 2
(Date:7/21/2015)... OXFORD, Connecticut , July 21, 2015 /PRNewswire/ ... the "Company"), a biometric authentication company focused on ... the Wocket® smart wallet, announces that it has ... Tokenization System and Method. This ... that not only authorizes an account, but also ...
(Date:7/13/2015)... , July 13, 2015 Synaptics ... of human interface solutions, today announced sampling of ... and display driver integration (TDDI) product targeting smartphones ... first to combine Synaptics , best-in-class touch ... display driver technology developed in the company,s Japan ...
(Date:7/9/2015)... , July 07, 2015 ... the addition of the "Biometrics for Banking; ... 2015-2020" report to their offering. ... contributor to this growth and the forecast is ... in revenue for companies involved in delivering biometric ...
Breaking Biology News(10 mins):NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 2NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 3NXT-ID Patents Personalized Tokenized Payments for Next Generation Secure Payment Technology 4Synaptics Announces Sampling of Second Generation TDDI Solutions 2Synaptics Announces Sampling of Second Generation TDDI Solutions 3Global Banking Biometrics Market 2015-2020 - Market & Technology Analysis, Adoption Strategies and Forecasts 2Global Banking Biometrics Market 2015-2020 - Market & Technology Analysis, Adoption Strategies and Forecasts 3
... by Georgia Tech and Emory University has received a ... a project aimed at reducing the incidence of stroke ... an assistant professor in the Wallace H. Coulter Department ... Health (NIH) funding to develop models for identifying which ...
... world,s rivers, the single largest renewable water resource for humans ... of ominous proportions, according to a new global analysis. ... Nature , is the first to simultaneously account for the ... the conversion of wetlands and the introduction of exotic species ...
... contrast to a toothed whale, which retains teeth that aid ... fin whale, humpback, bowhead) has lost its teeth and must ... or whalebone, a sieve-like structure in the upper jaw that ... on previous anatomical and fossil data studies, scientists have widely ...
Cached Biology News:$1.5M grant funds research aimed at reducing strokes in children with sickle cell disease 2$1.5M grant funds research aimed at reducing strokes in children with sickle cell disease 3$1.5M grant funds research aimed at reducing strokes in children with sickle cell disease 4Report casts world's rivers in 'crisis state' 2Report casts world's rivers in 'crisis state' 3Report casts world's rivers in 'crisis state' 4Researchers find first genetic evidence for loss of teeth in the common ancestor of baleen whales 2
... (GLYT2). The antiserum has been tested on ... The staining pattern obtained with AB1773 corresponds ... hybridization with probes to GLYT2 mRNA and ... neurons. Preabsorption of the antiserum with the ...
Anti-Potassium Channel Kv2.2 Immunogen: Synthetic peptide from rat Kv2.2. Available Date: 38376...
... an early protein. Can ... post-infection exhibiting an intranuclear inclusion ... between 6-24 hours. These ... granular staining. No other ...
MAb to Vasopressin Preservative: NaN3...
Biology Products: